Invivo therapeutics holdings corp. reports earnings results for the third quarter ended september 30, 2019

Invivo therapeutics holdings corp. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 2.732 million compared to usd 2.113 million a year ago. net loss was usd 2.679 million compared to usd 3.175 million a year ago. basic loss per share from continuing operations was usd 0.29 compared to usd 0.42 a year ago. for the nine months, operating loss was usd 8.758 million compared to usd 9.757 million a year ago. net loss was usd 8.458 million compared to usd 20.898 million a year ago. basic loss per share from continuing operations was usd 0.91 compared to usd 5.81 a year ago.
NVIV Ratings Summary
NVIV Quant Ranking